Site-discordant expression of myeloid cell nuclear differentiation antigen in blastic plasmacytoid dendritic cell neoplasm
Our findings suggest that MNDA expression in BPDCN is anatomic site dependent and transient, with noncutaneous infiltrates showing more frequent expression than cutaneous infiltrates. These results caution against the use of MNDA to exclude BPDCN when considering the differential diagnosis of a blastic extramedullary infiltrate.
Authors
- Yasodha Natkunam (ORCID: https://orcid.org/0000-0002-9816-1018)
- Kerri E. Rieger (ORCID: https://orcid.org/0000-0002-4436-2471)
- Ryanne A. Brown (ORCID: https://orcid.org/0000-0001-9099-7227)
- Atif Saleem (ORCID: https://orcid.org/0000-0002-3427-9762)
- Sebastian Fernandez‐Pol (ORCID: https://orcid.org/0000-0002-0428-0199)
- Philip L. Bulterys (ORCID: https://orcid.org/0000-0003-1382-743X)
- Roberto A. Novoa (ORCID: https://orcid.org/0000-0002-7955-0536)
Institutions
- Stanford University (US)
Publication Details
- Journal
- American Journal of Clinical Pathology
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1093/ajcp/aqae128
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00